On Tuesday, biotech and pharmaceutical companies urged president Donald Trump to reconsider his decision to end former president Barack Obama’s policy protecting undocumented immigrants who arrived in the U.S. as children. Attorney general Jeff Sessions said Tuesday morning that Trump would move to halt the Deferred Action for Childhood Arrivals program in six months, unless […]
Alnylam, The Medicines Co., detail Phase III trial for RNA-based heart drug
The Medicines Co. (NSDQ:MDCO) and Alnylam Pharmaceuticals (NSDQ:ALNY) said today that they’ve reached a deal with the FDA over a Phase III trial for the companies’ RNA-based cholesterol-lowering drug, inclisiran. If approved, it would be the 1st RNA-interference therapy on the market. The drug is a part of a new group of drugs called PCSK9 […]
Acuitas touts lipid-nanoparticle delivery of mRNA vaccine for Zika
Acuitas Therapeutics touted preliminary data that evaluated its messenger RNA vaccine for the Zika virus. The company uses a lipid-nanoparticle delivery system to introduce its mRNA vaccine into cells. The team’s work, which was published in Nature, showed that a single low-dose immunization with its vaccine triggered an immune response in animals and protected them from infection at […]
Codiak BioSciences lures Alnylam vet Sorensen to lead clinical program
Codiak BioSciences said today that it has named former Alnylam Pharmaceuticals (NSDQ:ALNY) executive Dr. Benny Sorensen as vice president and head of clinical development. Sorensen was Alnylam’s senior director of clinical research, leading the preclinical, clinical, regulatory and commercial strategies for hematology products. He also worked for Baxter (NYSE:BAX), advancing hematology therapies through Phase III pivotal development. Get the […]
Entegrion licenses clotting bandage to Boston device firm
For its 9th birthday, the biotech Entegrion is giving itself a present: a product on the market.
The Research Triangle Park, N.C.-based company struck a licensing deal with a Boston-based medical device company to manufacture and market Entegrion’s Stasilon bandage: a proprietary weave of glass and bamboo fibers that promotes clotting. CTO Joseph DaCorta wouldn’t name the company Beantown partner, but DaCorta did say that the business expects to make an announcement this week.
